phosphatidylcholines has been researched along with mitoxantrone in 6 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 4,555 | 1,042 | 1,004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bally, MB; Cullis, PR; Harrigan, PR; Loughrey, HC; Madden, TD; Mayer, LD; Redelmeier, TE; Reinish, LW; Tai, LC; Tilcock, CP | 1 |
| Bettaïeb, A; Jaffrézou, JP; Laurent, G; Levade, T; Mansat-De Mas, V; Plo, I; Quillet-Mary, A | 1 |
| Chen, T; Hou, SX; Lu, Y; Zheng, Y | 1 |
| Cui, J; Guo, W; Hao, Y; Li, C; Li, Y; Wang, C; Wang, J; Wang, Y; Zhang, H; Zhang, L | 1 |
| Cui, J; Guo, W; Li, C; Li, Y; Wang, C; Wang, J; Wang, Y; Zhang, L | 1 |
| Cui, J; Guo, W; Li, C; Li, Y; Liang, M; Wang, C; Wang, L; Yang, H; Zhang, L | 1 |
6 other study(ies) available for phosphatidylcholines and mitoxantrone
| Article | Year |
|---|---|
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
Topics: Anesthetics, Local; Antineoplastic Agents; Histamine H1 Antagonists; Hydrogen-Ion Concentration; Lipid Bilayers; Liposomes; Membranes, Artificial; Mitoxantrone; Phosphatidylcholines; Timolol | 1990 |
Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosis.
Topics: Apoptosis; Bridged-Ring Compounds; Ceramides; Daunorubicin; Diglycerides; DNA Fragmentation; Humans; Hydrolysis; Mitoxantrone; Norbornanes; Phosphatidylcholines; Protein Kinase C; Thiocarbamates; Thiones; Tumor Cells, Cultured | 1999 |
[Preparation and characterization of transfersomes of three drugs in vitro].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Colchicine; Deoxycholic Acid; Drug Carriers; Gout Suppressants; Mitoxantrone; Particle Size; Phosphatidylcholines; Solubility; Technology, Pharmaceutical; Vincristine | 2006 |
Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cholesterol; Copper; Copper Sulfate; Drug Compounding; Half-Life; Hydrogen-Ion Concentration; Injections, Intravenous; Ionophores; Liposomes; Male; Mice; Mitoxantrone; Neoplasms, Experimental; Nigericin; Phosphatidylcholines; Quaternary Ammonium Compounds; Solubility; Spectrum Analysis; Technology, Pharmaceutical | 2008 |
Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Compounding; Drug Screening Assays, Antitumor; Lipids; Liposomes; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Neoplasm Transplantation; Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Solubility; Tissue Distribution; Toxicity Tests, Acute | 2008 |
Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cholesterol; Dimyristoylphosphatidylcholine; Drug Compounding; Half-Life; Hydrogen-Ion Concentration; Injections, Intravenous; Liposomes; Male; Mice; Mitoxantrone; Neoplasms, Experimental; Nickel; Phosphatidylcholines; Solubility | 2009 |